|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online March 26, 2002 as doi:10.1096/fj.01-0916fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Centre for Cardiovascular Biology & Medicine, Guys, Kings & St. Thomas Schools of Biomedical Sciences and Medicine, Kings College London, Guys Campus, London SE1 1UL, UK
2Correspondence: Center for Cardiovascular Biology & Medicine, New Hunts House (Rm. 2.34B), GKT School of Biomedical Sciences, Kings College London, Guys Campus, London SE1 1UL, UK. E-mail: giovanni.mann{at}kcl.ac.uk
SPECIFIC AIMS
Preeclampsia (PE) is a leading cause of fetal and maternal mortality and is associated with abnormalities in maternal and fetal circulation. Our aim was to investigate whether fetal endothelial cells have abnormal free cytosolic calcium ([Ca2+]i) regulation that could be related to fetal vascular dysfunction.
PRINCIPAL FINDINGS
1. Ca2+ influx after histamine stimulation is reduced in PE endothelial cells
Fura-2 ratio fluorescence was used as a measure of [Ca2+]i in human umbilical vein endothelial cells from normal, PE, and age-matched preterm (PT) deliveries. The basal [Ca2+]i was slightly but significantly elevated in PE (compared with normal or PT); peak [Ca2+]i response to histamine stimulation was normal in PE. However, the plateau phase of the response to histamine (which reflects Ca2+ influx) was significantly depressed (Fig. 1
), with the median value being reduced by 43% (P<0.002). We also treated endothelial cells with histamine in Ca2+-free solution to Ca2+-deplete internal stores, with cyclopiazonic acid present to inhibit the store Ca2+ATPase and prevent any resequestration of Ca2+. We then measured the rise and fall of [Ca2+]i when extracellular Ca2+ was added to or removed from cells and found that the rate of rise of [Ca2+]i in PE cells was reduced by 65% (P<0.01) with no significant difference in the subsequent fall of [Ca2+]i. This confirmed that Ca2+ influx was inhibited in PE and not that plasma membrane Ca2+ATPase was stimulated.
|
2. Ba2+, Mn2+, and Gd3+ permeabilities are altered in PE endothelial cells
We used Fura-2 to investigate whether PE affected permeability to Mn2+ and Ba2+, both of which can be detected by Fura-2. Basal and histamine stimulated Mn2+ influx were substantially increased in PE (by 71%, P<0.05, and 232%, P<0.005, respectively), which for the stimulated influx was contrary to expectations based on the Ca2+ data. Ba2+, however, showed the same trend as Ca2+, with a 64% (P<0.03) reduction of influx in histamine-stimulated PE cells compared with normal. Suspecting modified divalent cation entry in PE, we tested to see whether Gd3+ differentially inhibited Ca2+ or Mn2+ entry in PE cells. We found that permeability to Gd3+ was elevated in PE (Fura-2 fluorescence is also sensitive to Gd3+) but undetectable in normal cells. The inhibitory action of Gd3+ on Ca2+ and Mn2+ entry was not significantly altered in PE.
3. Basal and histamine-stimulated eNOS activity is elevated in PE
We next examined whether the reduced Ca2+ influx under histamine-stimulated conditions correlated with reduced eNOS activity by measuring intracellular cGMP (an index of NO) in the presence of phosphodiesterase inhibition. We found no difference in [cGMP] between normal and PT cells, but NO production in PE cells was altered in a number of ways (Fig. 2
). Basal and histamine-stimulated [cGMP] were significantly elevated. We tested sensitivity to the eNOS inhibitor L-NAME and found that the L-NAME-resistant part of the elevation of cGMP was higher in PE for basal and stimulated levels. Immunoblots for eNOS and soluble guanylyl cyclase (sGC) proteins relative to
-tubulin revealed no difference for sGC between normal, PT, and PE cells. However, eNOS expression in PT and PE cells was reduced compared with normal cells.
|
4. Elevated cGMP in PE does not account for the depressed Ca2+ influx
As cGMP has been reported to inhibit Ca2+ influx, we examined whether the elevated levels of cGMP could account for the depressed Ca2+ plateau in PE. A cell-permeant analog of cGMP (100500 µM 8-bromo-cGMP) dose-dependently inhibited the plateau phase of the response to histamine in normal (21±4%) and PE cells (15±8%) by a similar amount, which was less than the depression of the plateau seen in PE vs. normal cells.
DISCUSSION
Preeclampsia occurs in
4% of pregnancies and is a leading cause of maternal and fetal morbidity and mortality: the disease is characterized by a pregnancy-related increase in blood pressure and significant proteinuria. Impaired endothelial dependent relaxation in the maternal circulation is a hallmark of PE; however, studies of the feto-placental circulation in PE are rare even though the feto-placental vasculature is often abnormal. There is no consensus regarding the functional status of the feto-placental vessels in PE, although some reports conclude that fetal endothelial cell function is compromised. Studies examining NO production in the fetal circulation in normal and PE pregnancies are controversial, with fetal serum concentrations of nitrite and nitrate either unchanged or elevated. Similar discrepancies have been reported for NO production in the maternal circulation, with lowered or unchanged circulating nitrite and nitrate levels in women with PE.
The present study provides important insights into abnormalities of fetal vascular endothelial cells isolated from women with PE. These alterations in endothelial cell function were sustained during culture in vitro and were characterized by 1) slightly elevated basal [Ca2+]i, 2) decreased histamine-stimulated Ca2+ influx, 3) altered membrane permeability to other multivalent cations, and 4) enhanced basal and histamine-stimulated rates of NO production.
Fetal endothelial cells obtained from PE pregnancies had a reduced agonist-stimulated [Ca2+] influx that resulted in a reduced plateau phase of the [Ca2+] response to histamine. Ca2+ entry in umbilical vein endothelial cells is known to be capacitative and triggered by depletion of internal Ca2+ stores, with the plateau Ca2+ level reflecting a balance between Ca2+ influx and efflux. Thus, we used Mn2+ influx to confirm that divalent cation entry was indeed inhibited in PE cells, but our measurements revealed a paradoxical increase in the histamine-stimulated permeability to Mn2+. Like Mn2+, Ba2+ is not transported by Ca2+ATPases, and thus is another good indicator of unidirectional divalent cation movement. Ba2+ influx was reduced in PE by 64% (P<0.03). The disparity between Ca2+/Ba2+ and Mn2+ entry in PE endothelial cells suggests either an alteration of the properties of store-operated Ca2+ entry or expression of different types of Ca2+ influx channels. To investigate this further, we tested whether PE altered the sensitivity of Ca2+ or Mn2+ entry to inhibition by Gd3+. Although our experiments revealed no significant differences in the inhibition of Mn2+ entry by Gd3+ between normal and PE cells, we identified increased permeability to Gd3+ in PE cells. This increase may correspond to a report that expression of stretch-operated channels, but not the channel conductance or sensitivity to stretch, is increased in PE umbilical vein endothelial cells. In summary, we have established that fetal endothelial cells from PE pregnancies exhibit a decreased permeability to Ca2+ and Ba2+ but an increased permeability to Mn2+ and Gd3+: this could be due to phenotypic alteration of a single influx pathway or a shift in the balance between different entry pathways with different relative permeabilities to Ca2+, Ba2+, Mn2+, and Gd3+. Recent evidence suggests that various modes of Ca2+ entry in nonexcitable cells are mediated by a family of transient receptor potential (TRP) proteins. At least three different isoforms of TRP channels (TRP 1,3,4) are expressed in umbilical vein endothelial cells, and regulation of their expression in normal and PE endothelial cells merits investigation. The recent report that incubation of rat aortic vascular smooth muscle cells with PE serum reduces Ca2+ transients and inhibits store-operated entry of Ca2+ and Ba2+ lends additional support to our hypothesis that PE is associated with phenotypic alterations in the entry pathway(s) for multivalent cations.
The control of eNOS activity by [Ca2+] i has been studied extensively; the consensus is that it is controlled mainly by Ca2+ influx rather than by Ca2+ released from internal stores. Although there is overwhelming evidence for endothelial cell activation and impaired dilator function in the maternal circulation in PE, there is no agreement concerning the feto-placental circulation, particularly in relation to the role of NO. We found that L-NAME-sensitive, histamine-stimulated cGMP accumulation was significantly increased in PE compared with normal and PT endothelial cells, implying increased generation of NO in PE. This increased production could not be accounted for by increased eNOS or sGC protein expression, and preliminary experiments suggested that the increased NO production is not due to Ca2+-independent activation of eNOS via Akt-mediated serine phosphorylation (unpublished data). Inducible NOS is not expressed in PE umbilical vein endothelial cells, and activation of sGC by CO generated via metabolism of heme by heme oxygenase is unlikely in view of the recent report that constitutive expression of HO-2 in placental villous endothelial cells is reduced in PE. The NO pathway can also be affected by reactive oxygen species; we have not investigated this, but its potential importance is indicated by the fact that supplementation with antioxidants markedly reduces the incidence of PE in women at risk.
Increased NO production appears inconsistent with the reduced Ca2+ influx detected in PE cells. A putative explanation for the decreased Ca2+ influx but increased NO production in PE is that eNOS is associated with plasmalemmal caveolae, but our Ca2+ measurements with Fura-2 report bulk cytosolic [Ca2+]. Thus, one might postulate distribution of the Ca2+ influx pathway, PMCA, and eNOS in PE cells that allows a greater fraction of the influx of Ca2+ to activate eNOS and be exported without reaching the cytosol and detection by Fura-2. However, this explanation is unlikely since we also observed a reduced entry with Ba2+, an ion not pumped by the PMCA and therefore a more reliable indicator of the unidirectional influx.
Another interpretation is that elevated intracellular cGMP levels may have suppressed plateau [Ca2+]i, since cGMP has been reported to reduce store-operated Ca2+ entry. It is unlikely that elevated cGMP levels in PE cells are directly responsible for the reduced plateau Ca2+ phase, as the cell-permanent analog 8-bromo-cGMP caused a similar depression of plateau [Ca2+]i in normal and PE cells (normal 21±4% vs. PE 15±8%) and the maximal depression of the plateau in normal and PE cells was insufficient to account for the low PE plateau. Even though we have identified altered Ca2+ regulation and NO production in PE endothelial cells, based on the present data we cannot directly link these two processes.
Perhaps one of the most interesting observations is that pregnancy-associated diseases induce phenotypic changes in the fetal vasculature. In the present study, alterations in Ca2+ regulation and NO production persisted during cell culture, suggesting that PE is associated with phenotypic alterations in the function of fetal endothelial cells. This may have implications for long-term programming of the fetal cardiovascular system, since programming of the fetus in PE was implied from one clinical study in which men whose mothers suffered from PE were found to be at increased risk of developing hypertension in adulthood.
|
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.01-0916fje; to cite this article, use FASEB J. (March 26, 2002) doi/10.1096/fj.01-0916fje; ![]()
This article has been cited by other articles:
![]() |
P. Lopez-Jaramillo, W. D. Arenas, R. G. Garcia, M. Y. Rincon, and M. Lopez Review: The role of the L-arginine-nitric oxide pathway in preeclampsia Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 261 - 275. [Abstract] [PDF] |
||||
![]() |
R. Farragher, C. H. Maharaj, B. D. Higgins, S. Crowe, P. Burke, C. D. Laffey, N. M. Flynn, and J. G. Laffey Sevoflurane and the Feto-Placental Vasculature: The Role of Nitric Oxide and Vasoactive Eicosanoids Anesth. Analg., July 1, 2008; 107(1): 171 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Gifford, F.-X. Yi, and I. M Bird Pregnancy-enhanced store-operated Ca2+ channel function in uterine artery endothelial cells is associated with enhanced agonist-specific transient receptor potential channel 3-inositol 1,4,5-trisphosphate receptor 2 interaction. J. Endocrinol., August 1, 2006; 190(2): 385 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Knock, A. S. De Silva, V. A. Snetkov, R. Siow, G. D. Thomas, M. Shiraishi, M. P. Walsh, J. P. T. Ward, and P. I. Aaronson Modulation of PGF2{alpha}- and hypoxia-induced contraction of rat intrapulmonary artery by p38 MAPK inhibition: a nitric oxide-dependent mechanism Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L1039 - L1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-X. Yi and I. M. Bird Pregnancy-Specific Modulatory Role of Mitochondria on Adenosine 5'-Triphosphate-Induced Cytosolic [Ca2+] Signaling in Uterine Artery Endothelial Cells Endocrinology, November 1, 2005; 146(11): 4844 - 4850. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. Zheng, I. M. Bird, and R. R. Magness Mechanisms of Shear Stress-Induced Endothelial Nitric-Oxide Synthase Phosphorylation and Expression in Ovine Fetoplacental Artery Endothelial Cells Biol Reprod, March 1, 2004; 70(3): 785 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez-Orgado, R. Gonzalez, M. J. Alonso, and M. Salaices Impairment of Fetal Endothelium-Dependent Relaxation in a Rat Model of Preeclampsia by Chronic Nitric Oxide Synthase Inhibition Reproductive Sciences, February 1, 2004; 11(2): 82 - 88. [Abstract] [PDF] |
||||
![]() |
G. E. Mann, D. L. Yudilevich, and L. Sobrevia Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells Physiol Rev, January 1, 2003; 83(1): 183 - 252. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |